Inventor

GHARBAOUI TAWFIK

US22 patents

⚠️ This page may combine multiple inventors who share the name “GHARBAOUI TAWFIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GHARBAOUI TAWFIK

ARENA PHARM INC

Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor

Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof

Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof

Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof

Processes for preparing pyrazolo[3,4-d]pyrimidine ethers

Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor

Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof

Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor

Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor

Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor

UNIV FLORIDA STATE

Taxane synthesis method and intermediates

Method for the synthesis of taxanes

Method for the synthesis of a taxane intermediate

GHARBAOUI TAWFIK

Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor

Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof

MIRATI THERAPEUTICS INC

Crystalline forms of a KRas G12C inhibitor

Crystalline forms of a KRas G12C inhibitor

MONTALBAN ANTONIO GARRIDO

Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof

JONES ROBERT M

Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof

ARENA PHARAMACEUTICALS INC

Processes for preparing aromatic ethers

SEMPLE GRAEME

Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof

CARLOS MARLON V

Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine